HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy.

AbstractPURPOSE:
To evaluate whether patients with metastatic gastrointestinal adenocarcinomas refractory to chemotherapy harbor tumor-reactive cytotoxic T cells.
EXPERIMENTAL DESIGN:
Expansion of CD8(+) tumor-infiltrating lymphocytes (TIL) and cancer cell lines was attempted from gastrointestinal cancer metastases in 16 consecutive patients for the study of antitumor immune recognition. Retroviral transduction of genes encoding T-cell receptors (TCR) was used to define HLA-restriction elements and specific reactivity.
RESULTS:
TIL were expanded from metastases in all patients, and new tumor cell lines were generated in 5 patients. Autologous tumor recognition without cross-reactivity against allogeneic HLA-matched gastrointestinal tumors was found in CD8(+) TIL from 3 of these 5 patients. In a patient with gastric cancer liver metastases, the repertoire of CD8(+) TIL was dominated by cytolytic sister clones reactive to 2 out of 4 autologous cancer cell lines restricted by HLA-C*0701. From the same patient, a rare CD8(+) TIL clone with a distinct TCR recognized all four cancer cell lines restricted by HLA-B*4901. In a patient with bile duct cancer, two distinct antitumor cytolytic clones were isolated from a highly polyclonal CD8(+) TIL repertoire. TCRs isolated from these clones recognized epitopes restricted by HLA-A*0201. In a third patient, CD8(+) TIL reactivity was progressively lost against an autologous colon cancer cell line that displayed loss of HLA haplotype.
CONCLUSIONS:
This study provides a basis for the development of immunotherapy for patients with advanced gastrointestinal malignancies by first establishing the presence of naturally occurring tumor-reactive CD8(+) TIL at the molecular level.
AuthorsSimon Turcotte, Alena Gros, Eric Tran, Chyi-Chia R Lee, John R Wunderlich, Paul F Robbins, Steven A Rosenberg
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 20 Issue 2 Pg. 331-43 (Jan 15 2014) ISSN: 1557-3265 [Electronic] United States
PMID24218514 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Copyright©2013 AACR.
Chemical References
  • Histocompatibility Antigens Class I
  • Receptors, Antigen, T-Cell
Topics
  • Adult
  • Autografts
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Cell Line, Tumor
  • Female
  • Gastrointestinal Neoplasms (genetics, immunology, pathology)
  • Histocompatibility Antigens Class I (immunology)
  • Humans
  • Lymphocytes, Tumor-Infiltrating (immunology, metabolism)
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Receptors, Antigen, T-Cell (genetics, immunology)
  • Transduction, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: